1 - 4 of 4 Results
Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).
This technology is a strategy for decreasing electromagnetic interference and boosting signal fidelity for low signal-to-noise sensors transmitting over long distances in extreme environments, such as nuclear energy generation applications, particularly for particle detection.
A diver-operated system brings safe and portable imaging to a new operating environment – underwater at depths up to 300 feet.
There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).